IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide

T cells are key players in immune-mediated rheumatoid arthritis (RA). We previously reported that interleukin (IL)-22(+)CD4(+)T helper (IL-22(+) Th) cells and IL-22 critically control the pathogenesis of RA. Here we monitored circulating levels of different IL-22(+) Th cell subsets and measured plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Wei, Zhao, Ling, Liu, Tao, Jiang, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259708/
https://www.ncbi.nlm.nih.gov/pubmed/28117352
http://dx.doi.org/10.1038/srep41143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259708/
https://www.ncbi.nlm.nih.gov/pubmed/28117352
http://dx.doi.org/10.1038/srep41143

Ejemplares similares